Last reviewed · How we verify
Belladonna and Opium — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Belladonna and Opium (Belladonna and Opium) — University of Washington. Belladonna/opium rectal suppository combines atropine and morphine to relax smooth muscles and increase pain threshold, respectively.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Belladonna and Opium TARGET | Belladonna and Opium | University of Washington | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Belladonna and Opium CI watch — RSS
- Belladonna and Opium CI watch — Atom
- Belladonna and Opium CI watch — JSON
- Belladonna and Opium alone — RSS
Cite this brief
Drug Landscape (2026). Belladonna and Opium — Competitive Intelligence Brief. https://druglandscape.com/ci/belladonna-and-opium. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab